Checkpoint Therapeutics, Inc. (CKPT) Social Stream
Checkpoint Therapeutics Inc (CKPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CKPT.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CKPT's average price target has moved up $6.7 over the prior 30 weeks.
CKPT reports an average of 510.14% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CKPT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CKPT's average broker recommendation rating improved by 0.67 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CKPT as an investment opportunity.
- In the context of all US stocks, Checkpoint Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 396.22% of them.
- To contextualize these metrics, consider that out of all US stocks, Checkpoint Therapeutics Inc's number of analysts covering the stock is higher than 76.32% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Checkpoint Therapeutics Inc's variance in analysts' estimates is lower than -18.92% of them.
- In the context of Healthcare stocks, Checkpoint Therapeutics Inc's average analyst price target is greater than 133.79% of them.
Is CKPT a Buy, Hold or Sell? See the POWR Ratings now!